Huang Chuan-Hsiang, Mandelker Diana, Schmidt-Kittler Oleg, Samuels Yardena, Velculescu Victor E, Kinzler Kenneth W, Vogelstein Bert, Gabelli Sandra B, Amzel L Mario
Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Science. 2007 Dec 14;318(5857):1744-8. doi: 10.1126/science.1150799.
PIK3CA, one of the two most frequently mutated oncogenes in human tumors, codes for p110alpha, the catalytic subunit of a phosphatidylinositol 3-kinase, isoform alpha (PI3Kalpha, p110alpha/p85). Here, we report a 3.0 angstrom resolution structure of a complex between p110alpha and a polypeptide containing the p110alpha-binding domains of p85alpha, a protein required for its enzymatic activity. The structure shows that many of the mutations occur at residues lying at the interfaces between p110alpha and p85alpha or between the kinase domain of p110alpha and other domains within the catalytic subunit. Disruptions of these interactions are likely to affect the regulation of kinase activity by p85 or the catalytic activity of the enzyme, respectively. In addition to providing new insights about the structure of PI3Kalpha, these results suggest specific mechanisms for the effect of oncogenic mutations in p110alpha and p85alpha.
PIK3CA是人类肿瘤中最常发生突变的两个致癌基因之一,编码p110α,即磷脂酰肌醇3激酶α亚型(PI3Kα,p110α/p85)的催化亚基。在此,我们报道了p110α与一种包含p85α的p110α结合结构域的多肽之间复合物的3.0埃分辨率结构,p85α是其酶活性所需的一种蛋白质。该结构表明,许多突变发生在p110α与p85α之间的界面处的残基上,或者发生在p110α的激酶结构域与催化亚基内的其他结构域之间的残基上。这些相互作用的破坏可能分别影响p85对激酶活性的调节或该酶的催化活性。除了为PI3Kα的结构提供新的见解外,这些结果还提示了p110α和p85α中致癌突变作用的具体机制。